Repurposing of Polio Vaccine in Prevention of COVID-19: Thinking towards more options
COVID-19 has created an unprecedented crisis worldwide in every sector. There currently is no approved drug available against this disease. The development of a vaccine is also a complex and long process that is often completed in 10-15 years. Recently, several vaccines for COVID-19 have received em...
Saved in:
Main Authors: | Awanish Kumar (Author), Sunil Kumar (Author), Dharmendra Pandey (Author) |
---|---|
Format: | Book |
Published: |
ACHSM,
2022-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Post-polio eradication: vaccination strategies and options for India
by: Jayakrishnan Thayyil, et al.
Published: (2014) -
Vaccine repurposing approach for preventing COVID 19: can MMR vaccines reduce morbidity and mortality?
by: Anand Anbarasu, et al.
Published: (2020) -
Implications of COVID-19 and "super floods" for routine vaccination in Pakistan: The reemergence of vaccine preventable-diseases such as polio and measles
by: Inayat Ali, et al.
Published: (2022) -
Impact of polio vaccines (oral polio vaccine - OPV or inactivated polio vaccine - IPV) on rotavirus vaccine-associated intussusception
by: Camila Cristina Martini Rodrigues, et al.
Published: (2022) -
Update on current and emerging treatment options for post-polio syndrome
by: Elisabeth Farbu
Published: (2010)